NanJing Pharmaceutical Company Limited (SHA:600713)
China
· Delayed Price · Currency is CNY 5.29
+0.07 (1.34%)
Jul 16, 2025, 2:45 PM CST
SHA:600713 Revenue
In the year 2024, NanJing Pharmaceutical Company had annual revenue of 53.70B CNY with 0.20% growth. NanJing Pharmaceutical Company had revenue of 12.76B in the quarter ending December 31, 2024, a decrease of -2.18%.
Revenue
53.70B
Revenue Growth
+0.20%
P/S Ratio
0.13
Revenue / Employee
11.12M
Employees
4,830
Market Cap
6.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53.70B | 106.51M | 0.20% |
| Dec 31, 2023 | 53.59B | 3.37B | 6.71% |
| Dec 31, 2022 | 50.22B | 5.10B | 11.30% |
| Dec 31, 2021 | 45.12B | 5.31B | 13.33% |
| Dec 31, 2020 | 39.82B | 2.66B | 7.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |